DocGo (NASDAQ:DCGO) is a provider of on-demand mobile healthcare services that combines traditional medical care with technology-enabled delivery models. The company offers a range of point-of-care solutions, including mobile paramedicine, infusion therapy, phlebotomy, wound care, immunizations, and virtual health consultations. By deploying clinics on wheels and partnering with health systems, payors, employers, and municipalities, DocGo seeks to reduce pressure on traditional care settings and improve patient access to timely, convenient services.
Since its founding in 2013, DocGo has expanded from a local mobile IV therapy provider into a national healthcare platform. The company has pursued both organic growth and strategic acquisitions to broaden its service mix and enter new markets. In 2023, DocGo completed a business combination through a special purpose acquisition company (SPAC) and began trading on the NASDAQ under the ticker DCGO, positioning itself for accelerated expansion and innovation.
DocGo currently operates in over 30 metropolitan areas across the United States, with notable footprints in Texas, Florida, California, New York and Pennsylvania. Its solutions are deployed at large community events, corporate campuses, senior living centers, schools and underserved communities. These deployments underscore the company’s objective to meet patients where they live and work, while addressing staffing challenges and cost constraints faced by traditional providers.
DocGo’s leadership team is led by co-founders and senior executives with deep experience in healthcare delivery, technology integration and operations management. Supported by a board of directors that includes industry veterans from major health systems and venture-backed technology firms, the company is focused on scaling its digital and mobile platform to transform lower-acuity, community-based care.
